|
1
|
Gray RE and Harris GT: Renal cell
carcinoma: Diagnosis and management. Am Fam Physician. 99:179–184.
2019.PubMed/NCBI
|
|
2
|
Padala SA and Barsouk A, Thandra KC,
Saginala K, Mohammed A, Vakiti A, Rawla P and Barsouk A:
Epidemiology of renal cell carcinoma. World J Oncol. 11:79–87.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen Q, Zheng RS, Zhang SK, Zhang SW, Liu
SZ, Sun XB, Wei WW and He J: Cancer incidence and mortality of
kidney and unspecified urinary organs in China, 2015. Zhonghua
Zhong Liu Za Zhi. 42:1001–1006. 2020.(In Chinese). PubMed/NCBI
|
|
5
|
Tang T, Du X, Zhang X, Niu W, Li C and Tan
J: Computational identification and analysis of early diagnostic
biomarkers for kidney cancer. J Hum Genet. 64:1015–1022. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Maestroni U, Gasparro D, Ziglioli F,
Guarino G and Campobasso D: Metastatic clear cell renal cell
carcinoma: The great pretender and the great dilemma. World J
Oncol. 12:178–182. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guo Q, Zhang C, Guo X, Tao F, Xu Y, Feng
G, Han X, Ren Z, Zhang H, Zhang P, et al: Incidence of bone
metastasis and factors contributing to its development and
prognosis in newly diagnosed renal cell carcinoma: A
population-based study. Cancer Manag Res. 10:2935–2944. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lai GS, Li JR, Wang SS, Chen CS, Yang CK,
Hung SC, Cheng CL, Ou YC and Chiu KY: Tumor size significantly
affects prognosis in pathological T3a renal cell carcinoma.
Anticancer Res. 42:2185–2191. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Demasure S, Spriet I, Debruyne PR, Laenen
A, Wynendaele W, Baldewijns M, Dumez H, Clement PM, Wildiers H,
Schöffski P, et al: Overall survival improvement in patients with
metastatic clear-cell renal cell carcinoma between 2000 and 2020: A
retrospective cohort study. Acta Oncol. 61:22–29. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao Y and Wang X: PLK4: A promising
target for cancer therapy. J Cancer Res Clin Oncol. 145:2413–2422.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mbefo MK, Paleologou KE, Boucharaba A,
Oueslati A, Schell H, Fournier M, Olschewski D, Yin G, Zweckstetter
M, Masliah E, et al: Phosphorylation of synucleins by members of
the Polo-like kinase family. J Biol Chem. 285:2807–2822. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hoffmann I: Role of polo-like kinases Plk1
and Plk4 in the initiation of centriole duplication-impact on
cancer. Cells. 11:7862022. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liao Z, Zhang H, Fan P, Huang Q, Dong K,
Qi Y, Song J, Chen L, Liang H, Chen X, et al: High PLK4 expression
promotes tumor progression and induces epithelialmesenchymal
transition by regulating the Wnt/betacatenin signaling pathway in
colorectal cancer. Int J Oncol. 54:479–490. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou Q, Fan G and Dong Y: Polo-like kinase
4 correlates with greater tumor size, lymph node metastasis and
confers poor survival in non-small cell lung cancer. J Clin Lab
Anal. 34:e231522020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Singh CK, Denu RA, Nihal M, Shabbir M,
Garvey DR, Huang W, Iczkowski KA and Ahmad N: PLK4 is upregulated
in prostate cancer and its inhibition reduces centrosome
amplification and causes senescence. Prostate. 82:957–969. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Holland AJ and Cleveland DW: Polo-like
kinase 4 inhibition: A strategy for cancer therapy? Cancer Cell.
26:151–153. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang X, Wei C, Liang H and Han L:
Polo-like kinase 4′s critical role in cancer development and
strategies for Plk4-targeted therapy. Front Oncol. 11:5875542021.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang Z, Sun H, Ma W, Wu K, Peng G, Ou T
and Wu S: Down-regulation of Polo-like kinase 4 (PLK4) induces G1
arrest via activation of the p38/p53/p21 signaling pathway in
bladder cancer. FEBS Open Bio. 11:2631–2646. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Garvey DR, Chhabra G, Ndiaye MA and Ahmad
N: Role of polo-like kinase 4 (PLK4) in epithelial cancers and
recent progress in its small molecule targeting for cancer
management. Mol Cancer Ther. 20:632–640. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dongre A and Weinberg RA: New insights
into the mechanisms of epithelial-mesenchymal transition and
implications for cancer. Nat Rev Mol Cell Biol. 20:69–84. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang G, Zhang Z and Liu Z: Polo-like
kinase 1 is overexpressed in renal cancer and participates in the
proliferation and invasion of renal cancer cells. Tumour Biol.
34:1887–1894. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hu Z, Gu X, Zhong R and Zhong H:
Tumor-infiltrating CD45RO(+) memory cells correlate with favorable
prognosis in patients with lung adenocarcinoma. J Thorac Dis.
10:2089–2099. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Oken MM, Creech RH, Tormey DC, Horton J,
Davis TE, McFadden ET and Carbone PP: Toxicity and response
criteria of the eastern cooperative oncology group. Am J Clin
Oncol. 5:649–655. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kazazian K, Go C, Wu H, Brashavitskaya O,
Xu R, Dennis JW, Gingras AC and Swallow CJ: Plk4 promotes cancer
invasion and metastasis through Arp2/3 complex regulation of the
actin cytoskeleton. Cancer Res. 77:434–447. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mittal K, Kaur J, Sharma S, Sharma N, Wei
G, Choudhary I, Imhansi-Jacob P, Maganti N, Pawar S, Rida P, et al:
Hypoxia drives centrosome amplification in cancer cells via
HIF1alpha-dependent Induction of Polo-Like Kinase 4. Mol Cancer
Res. 20:596–606. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kim DH, Ahn JS, Han HJ, Kim HM, Hwang J,
Lee KH, Cha-Molstad H, Ryoo IJ, Jang JH, Ko SK, et al: Cep131
overexpression promotes centrosome amplification and colon cancer
progression by regulating Plk4 stability. Cell Death Dis.
10:5702019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Holland AJ, Lan W, Niessen S, Hoover H and
Cleveland DW: Polo-like kinase 4 kinase activity limits centrosome
overduplication by autoregulating its own stability. J Cell Biol.
188:191–198. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kurinna S, Stratton SA, Coban Z,
Schumacher JM, Grompe M, Duncan AW and Barton MC: P53 regulates a
mitotic transcription program and determines ploidy in normal mouse
liver. Hepatology. 57:2004–2013. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nakamura T, Saito H and Takekawa M: SAPK
pathways and p53 cooperatively regulate PLK4 activity and
centrosome integrity under stress. Nat Commun. 4:17752013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li J, Tan M, Li L, Pamarthy D, Lawrence TS
and Sun Y: SAK, a new polo-like kinase, is transcriptionally
repressed by p53 and induces apoptosis upon RNAi silencing.
Neoplasia. 7:312–323. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cao T, Yi S, Yang X and Wu Q: Clinical
significance of polo-like kinase 4 as a marker for advanced tumor
stage and dismal prognosis in patients with surgical gastric
cancer. Technol Cancer Res Treat. 19:15330338209355312020.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kahl I, Mense J, Finke C, Boller AL,
Lorber C, Győrffy B, Greve B, Götte M and Espinoza-Sánchez NA: The
cell cycle-related genes RHAMM, AURKA, TPX2, PLK1, and PLK4 are
associated with the poor prognosis of breast cancer patients. J
Cell Biochem. 123:581–600. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhao JZ, Ye Q, Wang L and Lee SC:
Centrosome amplification in cancer and cancer-associated human
diseases. Biochim Biophys Acta Rev Cancer. 1876:1885662021.
View Article : Google Scholar : PubMed/NCBI
|
